PRESS RELEASE published on 10/17/2023 at 07:45, 2 years 6 months ago Marinomed Biotech AG resumes Nice & Green Convertible Notes Funding Program with reduced volume
PRESS RELEASE published on 08/17/2023 at 07:45, 2 years 8 months ago Marinomed Biotech AG reports record revenues in the first half of the year and pushes business development activities
PRESS RELEASE published on 08/09/2023 at 07:45, 2 years 8 months ago Marinomed enters first long-term Solv4U partnership with Shanghaibased SPH Sine Pharmaceutical Laboratories Co. Ltd.
PRESS RELEASE published on 07/27/2023 at 07:45, 2 years 9 months ago Marinomed Biotech AG: M8 Pharmaceuticals obtains market authorization for Carragelose nasal spray in Mexico
PRESS RELEASE published on 07/13/2023 at 07:45, 2 years 9 months ago Peer-reviewed publication by Marinomed Biotech AG and Friedrich-Alexander-University Erlangen-Nürnberg reconfirms broad virus-blocking effectiveness of iota-carrageenan
PRESS RELEASE published on 06/21/2023 at 17:00, 2 years 10 months ago Marinomed Biotech AG: Annual General Meeting elects Dr. Eva Hofstädter-Thalmann as a new member of the Supervisory Board
PRESS RELEASE published on 06/15/2023 at 07:45, 2 years 10 months ago Marinomed Biotech AG prepares launch of Carragelose eye drops in 2024
PRESS RELEASE published on 05/23/2023 at 07:45, 2 years 11 months ago Marinomed Biotech AG reports best first quarter in company history
PRESS RELEASE published on 04/19/2023 at 07:45, 3 years ago Marinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023
PRESS RELEASE published on 04/12/2023 at 07:45, 3 years ago Marinomed Biotech AG publishes clinical data on the effectiveness of its Carragelose nasal spray in the treatment of hay fever
Published on 05/08/2026 at 00:45, 49 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 1 hour 34 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 2 hours 4 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 2 hours 19 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 22:05, 3 hours 29 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 23:23, 2 hours 10 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 2 hours 19 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 3 hours 29 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 4 hours 51 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 6 hours 48 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 6 hours 19 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 6 hours 19 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 6 hours 28 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 6 hours 28 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 6 hours 34 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
